Product logins

Find logins to all Clarivate products below.


chevron_left

Informed Risk Assessment

Speakers

One of the biggest challenges the pharma industry continues to face today is the failure of drug candidates due to unexpected adverse reactions. Late-stage clinical attrition for safety reasons represents a high risk in terms of patient safety and cost. Early anticipation of safety issues enables informed decisions.

In this session we will present how OFF-X’s analytic tools and curated data from a broad range of sources can help de-risk drug development.

Agenda:

  • Challenges the pharma industry continues to face today
  • How the safety intelligence tool OFF-X can help de-risk drug development
  • Drug – Semagacestat
  • Target – BTK inhibitors
  • Target- 4-1BB activators
  • Summary